María Luz
Alonso Alonso
Instituto de Salud Carlos III
Madrid, EspañaInstituto de Salud Carlos III -ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2015
-
Clinically used selective oestrogen receptor modulators increase LDL receptor activity in primary human lymphocytes
British Journal of Pharmacology, Vol. 172, Núm. 5, pp. 1379-1394